India 3D Imaging Market Analysis Report 2022 to 2030

India 3D Imaging Market Analysis

$ 3999

India's 3D imaging market is projected to grow from $ 0.55 Bn in 2022 to $ 2.30 Bn by 2030, registering a CAGR of 19.5% during the forecast period of 2022-30. The market will be driven by increasing healthcare spending and positive government initiatives. The market is segmented by product, by application, end-user & by portability. Some of the major players include GE Healthcare, Siemens Healthineers & Philips Healthcare.

ID: IN10INDH001 CATEGORY: Digital Health GEOGRAPHY: India AUTHOR: Vidhi Upadhyay

Buy Now

India 3D Imaging Market Executive Summary

India's 3D imaging market is projected to grow from $ 0.55 Bn in 2022 to $ 2.30 Bn by 2030, registering a CAGR of 19.5% during the forecast period of 2022-30. According to World Health Organization (WHO) Global Health Expenditure database, health expenditure of India has grown from $60.27 per person (2.95% of GDP) in 2018 to $ 63.75 per person (3.01% of GDP) in 2019. According to reports, around 21% of the elderly in India suffer at least one chronic condition and the likelihood of having the same is 1.15 times higher in urban inhabitants than in rural residents. Diabetes, stroke, cancer, hypertension, and heart/cardiovascular ailments are the most prevalent ones in India making it a large market space for the 3D Imaging market to aid better diagnostics and treatments for patients.

3D imaging produces a three-dimensional representation of a patient's inner anatomy, providing accurate anatomical information and aiding in the diagnosis and monitoring of a number of medical disorders.3D applications of Computed Tomography (CT) scans, Magnetic Resonance Imaging (MRI) scans, X-ray Imaging Systems, 3D ultrasonography, and Nuclear Imaging systems are all used in a variety of medical fields including cardiology, neurology, cancer, gynecology, and orthopedics.

In February 2023, Abdul Latif Jameel Health, made a distribution agreement with iSono Health, to launch a portable breast imaging scanner called “ATUSA scanner” across 31 countries including India. It is the world’s 1^st AI-driven portable 3D Breast ultrasound scanner. “Metropolis Healthcare”, a diagnostic company network, purchased a 51% share in “Shraddha Diagnostic Centre” in January 2020 for Rs 9.36 crores ($1.27 million). This acquisition expands Metropolis Healthcare's geographical reach in India to 9 cities and towns.

India 3D imaging market analysis

Market Dynamics

Market Growth Drivers

In India, one in four people is likely to die of chronic disease. India is the fourth biggest country in Asia, behind Japan, China, and South Korea, and is in the top 20 countries in terms of medical imaging procedure consumption due to the high population with growing demand for imaging techniques, especially those that are detailed and accurate. The emergence of enhanced data storage and information-sharing methods, such as medical cloud technology, is expanding the market for 3D imaging. This is due to the fact that 3D imaging needs enough resources to process, preserve, transmit, and utilize massive amounts of medical data in order to make proper diagnostic and treatment decisions, and modern cloud computing in medical imaging answers these problems. The Indian government has made major expenditures in the healthcare industry, including advanced 3D imaging technology development. This assistance has aided in the expansion of the 3D imaging market in India by increasing its availability and cost.

Market Restraints

According to the International Labor Organization, there is a global shortage of approximately 10.3 million trained health professionals, with Asia accounting for more than half of the shortage (7.1 million, or 69%). This shortage of competent professionals may result in reduced imaging quality and higher patient expenditures eventually leading to a slowdown in market growth.

Moreover, the high expense of 3D imaging technology and the inability of many patients, particularly in rural regions, to purchase it is a major impediment. The regulatory framework for 3D imaging in India might create entry barriers for new market players. In some areas, limited infrastructure, such as electricity and internet access, might hinder the adoption of modern imaging tools. Traditional imaging techniques such as X-rays and CT scans, which are less expensive and more accessible are highly preferable in India.

Competitive Landscape

Key Players

GE Healthcare
Siemens Healthineers
Philips Healthcare
Canon Medical Systems
Toshiba Medical Systems
Hitachi Medical Systems
BPL Medical Technologies (IND)
DÜRR DENTAL India Private Limited (IND)

Notable Deals

January 2023, Canon Medical Systems Corporation announced a Partnership with ScImage, Inc., as it plans to expand in image exchange solutions and the cardiac market. Erbis Engineering Co is the official distributor of Canon Medical Systems Corporation in India
In November 2022, GE HealthCare announced partnerships with Accuray, Elekta, and RaySearch to combine GE HealthCare's imaging capabilities with precision radiation therapy to give cancer patients early diagnosis and improved treatment alternatives

Healthcare Policies and Regulatory Landscape

In India, the Central Drugs Standard Control Organization (CDSCO), which is part of the Ministry of Health and Family Welfare, is the regulatory body for medical equipment, including 3D imaging systems. The CDSCO is in charge of defining medical device standards and guaranteeing their safety and efficacy. The Indian government has put in place a number of policies and measures to stimulate the expansion of the medical device sector, The "Make in India" campaign, for example, intends to make India a worldwide manufacturing powerhouse by encouraging local production and boosting the country's competitiveness in the global market.

Reimbursement Scenario

Ayushman Bharat, a flagship scheme of the Government of India, was launched as recommended by the National Health Policy 2017, to achieve the vision of Universal Health Coverage (UHC). Ayushman Bharat PM-JAY is the world's largest government-funded health insurance/assurance plan. It covers Rs. 5 lakhs per family per year for secondary and tertiary care hospitalization in India's public and private enrolled facilities.

1. Executive Summary
1.1 Digital Health Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Digital Health Policy in Country
1.6 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

India 3D Imaging Market Segmentation

By Product (Revenue, USD Billion):

The 3D Imaging Market is divided majorly into X-ray Imaging Systems, Computed Tomography (CT), Magnetic Resonance Imaging (MRI), Ultrasound & Nuclear Imaging Systems. X-ray Imaging systems have the highest market share in the 3D Imaging market. 3D X- rays are mostly utilized for dental and orthopedic applications. 3D Ultrasound is majorly helpful in tracking the dynamic motion of arteries, and veins and also has applications for various fetal, cardiac, obstetric, and rectal examinations, and many more. The ultrasound segment is predicted to develop substantially over the forecast period, primarily to the advancements in technology in the healthcare industry and the several advantages given by 3D ultrasound imaging over standard ultrasound imaging.

X-ray Imaging Systems
Computed Tomography (CT)
Magnetic Resonance Imaging (MRI)
Ultrasound
Nuclear Imaging systems

By Application (Revenue, USD Billion):

The market for 3D Imaging has applications covering Cardiology, Neurology, Orthopaedics, Gynaecology, Oncology, and other areas of diagnostics as well. Cardiovascular diseases are the leading cause of death globally. The second biggest cause is cancers because of which Oncology holds the highest market share in the 3D Imaging market followed by cardiology as 3D imaging is highly utilized in these two segments for diagnostics and treatments of the same. Neurosurgeons desire three-dimensional (3D) imagery of intracranial tumors, neural structures, skulls, and veins to establish a clear visual image of the surgical field's anatomical orientation prior to surgical intervention aiding better surgical outcomes for patients. Obstetricians employ 3D ultrasound scans to see the gestational sac, pinpoint the location of an ectopic pregnancy, and evaluate for fetal deformities of the face, spine, limbs, and heart. 3D Imaging applications for gynecology are yet in evolving stage and have a great scope for expansion allowing feasible and quick patient care.

Cardiology
Neurology
Orthopedics
Gynecology
Oncology
Others (Urology, etc.)

By End User (Revenue, USD Billion):

Hospitals, Diagnostic Imaging Centers, and other end-user such as private clinics make up the segments of the 3D Imaging Market. The hospitals among these hold the biggest market share due to the increased uptake of cutting-edge medical technology, the expansion of existing 3D Imaging facilities, the rising affordability of 3D Imaging services, the rising prevalence of chronic conditions such as cardiovascular diseases, cancers, respiratory diseases which lead to rising in demand for precise and quick diagnostic and treatment options. Diagnostic Imaging Centers have also been deploying 3D Imaging equipment to improve their standard of care.

Hospitals
Diagnostic Imaging Centers
Other End Users

By Portability (Revenue, USD Billion):

The 3D Imaging market is divided into two segments Stationary & Mobile, considering the portability of the device. Stationary 3D imaging involves equipment that is installed at a particular location and is operated from the same location of installment whereas mobile ones can be relatively smaller in size and hence moved to the patients who are unable to locate the Imaging room. Mobile MRI, Ultrasound, X–ray & CT allow cutting-edge healthcare to be delivered to nearly any location and are yet in the developing stages of expansion.

Stationary
Mobile

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.